According to behavioral economists, this is because of their early experiences.
Time can be a double-edged sword, regardless of how long you've been investing or how new you are.
Investing is a long-term endeavo...
Following the money is one of the best ways to determine how other investors feel about the market.
According to an analysis of etfbook . com data from investment manager Fidelity International, the cash flows into and ...
The FCA's predictions for the development of AI in financial services and the associated risks.brbrAccording to research conducted by the Financial Conduct Authority (FCA), millions of savers and investors are already using...
Will Labour leader Andy Burnham protect it?
Keir Starmer pledged not to interfere with the triple lock, which guarantees an increase in the state pension every April based on the average earnings growth rate, inflation ...
In light of new transparency regulations that will be implemented next year, cryptocurrency investors are being advised to make sure they have reported any capital gains to HMRC or risk fines totaling hundreds of pounds.
...
If Burnham is elected as the next leader of the Labour Party, there are rumoured plans to force tens of thousands more households to pay the mansion tax.
According to reports in The Mail on Sunday, the prime minister-in...
The government has proposed new regulations that will grant cohabiting couples who are not married or in a civil partnership new financial rights.
According to the proposals, unmarried partners may be granted automatic ...
Although they have been overshadowed by their larger counterparts, UK small and mid-cap stocks are starting to make a comeback. The FTSE 250 has outperformed the FTSE 100 by about 6% since the beginning of April, which is notew...
How can you be exposed to more conventional media?
In the financial world, the most important factor is whether or not the stock market is included in the MSCI Emerging Markets (EM) index. You can argue over various met...
Dr. Douglas Williams has served on the boards of multiple biotech companies and is an experienced senior executive. Enbrel, Tecfidera, and Spinraza are just a few of the multibillion-dollar treatments he helped develop while wo...